Primary Sclerosing Cholangitis
Membership Organizations · 1-10 Employees
View Company Info for Free
Overview
Phone Number
(312) 695-9400Website
www.livingwithpsc.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Primary Sclerosing Cholangitis
Living with PSC is a free online community dedicated to supporting individuals affected by Primary Sclerosing Cholangitis (PSC) and their caregivers. The platform allows members to connect, share experiences, and access valuable resources in a safe environment. It aims to alleviate feelings of isolation by fostering connections among patients, family members, and caregivers. The community is part of Bens Friends, a network focused on providing support for those with rare diseases.Explore more
Popular SearchesPrimary Sclerosing CholangitisBen's FriendsSIC Code 86,869NAICS Code 81,813Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Primary Sclerosing Cholangitis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Primary Sclerosing Cholangitis, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Primary Sclerosing Cholangitis
Check if Primary Sclerosing Cholangitis has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Primary Sclerosing Cholangitis has new funding data
Earning: See what the market has to say on Primary Sclerosing Cholangitis recently announced quarterly report
Check out if Primary Sclerosing Cholangitis is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Primary Sclerosing Cholangitis had a recent Job posting/layoffs
Product Launch: Get notified when Primary Sclerosing Cholangitis launches new products
Recommended Actions
Reach out to Masked Content who joined Primary Sclerosing Cholangitis as Masked Content
Find more new buyers
Compare Similar Companies to Primary Sclerosing Cholangitis
Compare insights from companies similar to Primary Sclerosing Cholangitis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Primary Sclerosing Cholan...
<$5M
1-10
Private
-
2013
N/A
Company Profile Activity
Activity Insights
Primary Sclerosing Cholangitis is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Primary Sclerosing Cholangitis is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Primary Sclerosing Cholangitis.
Primary Sclerosing Cholangitis Tech Stack
A closer look at the technologies used by Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis News & Media
Global Primary Sclerosing Cholangitis Market 2017-2020 & 2030 Featuring Gilead Sciences, HighTide Biopharma, NGM Biopharmaceuticals, Intercept Pharmaceuticals, Dr Falk Pharma
Dublin, Oct. 14, 2020 (GLOBE NEWSWIRE) -- The "Primary Sclerosing Cholangitis - Market Insights, Epidemiology and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing Cholangitis - Market Insights, Epidemiology and Forecast to 2030 delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Primary Sclerosing Cholangitis in the United States, EU5 (Germany, France, Italy, Spain, and the UnitGlobal Primary Sclerosing Cholangitis Market Insights, Epidemiology and Forecast to 2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Primary Sclerosing Cholangitis - Market Insights, Epidemiology and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing Cholangitis - Market Insights, Epidemiology and Forecast to 2030 delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Primary Sclerosing Cholangitis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), andPrimary Sclerosing Cholangitis Epidemiology Forecast to 2030 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Primary Sclerosing Cholangitis - Epidemiology Forecast to 2030 delivers an in-depth understanding of the disease, historical, and forecasted Primary Sclerosing Cholangitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Primary Sclerosing Cholangitis: Understanding The P
Read more news
Top Membership Organizations Companies
Frequently Asked Questions Regarding Primary Sclerosing Cholangitis
Sign Up For FreeTo access detailed company insights
Living with PSC is a free online community dedicated to supporting individuals affected by Primary Sclerosing Cholangitis (PSC) and their caregivers. The platform allows members to connect, share experiences, and access valuable resources in a safe environment. It aims to alleviate feelings of isolation by fostering connections among patients, fami... Read More
